About Neosoma
Neosoma is a private company based in Groton, Massachusetts. It has reported $10,175,579 raised in five offerings on Form D since November 2020. Its chief executive is Kenneth Kolodziej.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 18, 2026 | Mar 27, 2026 | $3,517,368of $5.8M target | 52 | $67,642 | EquityRule 506(b) | Form D ↗ |
| Dec 24, 2024 | Jan 8, 2025 | $345,000of $800K target | 5 | $69,000 | Debt, OptionsRule 506(b) | Form D ↗ |
| Jul 11, 2024 | Jul 26, 2024 | $5,053,211of $5.7M target | 54 | $93,578 | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Aug 16, 2023 | Aug 31, 2023amended Feb 13, 2024 | $1,185,000of $3.1M target | 15 | $79,000 | Debt, OptionsRule 506(b) | Form D/A ↗1 earlier filing |
| Nov 5, 2020 | Nov 20, 2020 | $75,000of $750K target | 2 | $37,500 | Debt, OptionsRule 506(b) | Form D ↗ |
| Total, five offerings | $10,175,579 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Neosoma's Form D filed Mar 27, 2026.

Earlier filings also listed Oleg Ikhelson (director, last listed Jan 2025), John Liedtky (executive officer, last listed Jan 2025), Deborah Millin (director, last listed Jan 2025) and Aly Abayazeed (executive officer and director, last listed Feb 2024).
